Works matching DE "BEVACIZUMAB"

Results: 5000

Efficacy, safety, and cost-effectiveness of biosimilars of bevacizumab in näive patients with diabetic macular edema.

Published in:

Indian Journal of Pharmacology, 2024, v. 56, n. 4, p. 248, doi. 10.4103/ijp.ijp_58_24

By:

Virani, Shalini;
Bhatiwal, Akshay;
Rewri, Parveen

Publication type:

Article

Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab.

Published in:

Indian Journal of Pharmacology, 2022, v. 54, n. 4, p. 295, doi. 10.4103/ijp.ijp_11_22

By:

Mentesoglu, Dilek;
Gunaydin, Sibel;
Ersoy-Evans, Sibel;
Atakan, Nilgun;
Gokoz, Ozay;
Karadag, Omer;
Kilickap, Saadettin

Publication type:

Article

Bevacizumab for eye diseases – Legal, regulatory, and ethical overview.

Published in:

Indian Journal of Pharmacology, 2019, v. 51, n. 6, p. 377, doi. 10.4103/ijp.IJP_413_19

By:

Jose, Vinu;
Radhakrishna, Swetha;
Pipalava, Parag;
Singh, Inderjeet

Publication type:

Article

Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma.

Published in:

Indian Journal of Pharmacology, 2014, v. 46, n. 1, p. 125, doi. 10.4103/0253-7613.125195

By:

Şendur, Mehmet A. N.;
Aksoy, Sercan;
Özdemir, Nuriye Yıldırım;
Zengin, Nurullah

Publication type:

Article

A case study of a patient with platelet transfusion refractoriness (PTR) combined with human leucocyte antigen (HLA) antibody positivity during hepatic arterial infusion chemotherapy in conjunction with the 'atezolizumab plus bevacizumab' regimen.

Published in:

Nursing in Critical Care, 2025, v. 30, n. 2, p. 1, doi. 10.1111/nicc.13118

By:

Xie, Yawen;
Huang, Yanxia;
Liu, Shuyue

Publication type:

Article

The ineligible patient: how to treat patients not included in clinical studies.

Published in:

World Journal of Urology, 2014, v. 32, n. 1, p. 9, doi. 10.1007/s00345-013-1042-2

By:

Mao, Frances;
Rini, Brian

Publication type:

Article

Targeted therapy in renal cell carcinoma.

Published in:

World Journal of Urology, 2008, v. 26, n. 2, p. 135, doi. 10.1007/s00345-008-0237-4

By:

Patard, Jean-Jacques;
Pouessel, Damien;
Bensalah, Karim;
Culine, Stéphane

Publication type:

Article

A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors.

Published in:

Child's Nervous System, 2022, v. 38, n. 5, p. 919, doi. 10.1007/s00381-022-05479-7

By:

Metts, Jonathan;
Harrington, Brittany;
Salman, Emad;
Bradfield, Scott M.;
Flanary, Jennifer;
Mosha, Maua;
Amankwah, Ernest;
Stapleton, Stacie

Publication type:

Article

Managing NF2-associated vestibular schwannomas in children and young adults: review of an institutional series regarding effects of surgery and bevacizumab on growth rates, tumor volume, and hearing quality.

Published in:

Child's Nervous System, 2020, v. 36, n. 10, p. 2471, doi. 10.1007/s00381-020-04728-x

By:

Gugel, Isabel;
Zipfel, Julian;
Hartjen, Philip;
Kluwe, Lan;
Tatagiba, Marcos;
Mautner, Victor-Felix;
Schuhmann, Martin Ulrich

Publication type:

Article

New treatment modalities in NF-related neuroglial tumors.

Published in:

Child's Nervous System, 2020, v. 36, n. 10, p. 2377, doi. 10.1007/s00381-020-04704-5

By:

Packer, Roger J.;
Vezina, Gilbert

Publication type:

Article

Bevacizumab for optic pathway glioma with worsening visual field in absence of imaging progression: 2 case reports and literature review.

Published in:

Child's Nervous System, 2020, v. 36, n. 3, p. 635, doi. 10.1007/s00381-019-04407-6

By:

Yamasaki, Fumiyuki;
Takano, Motoki;
Yonezawa, Ushio;
Taguchi, Akira;
Kolakshyapati, Manish;
Okumichi, Hideaki;
Kiuchi, Yoshiaki;
Kurisu, Kaoru

Publication type:

Article

Bevacizumab in the treatment of radiation injury for children with central nervous system tumors.

Published in:

Child's Nervous System, 2019, v. 35, n. 11, p. 2043, doi. 10.1007/s00381-019-04304-y

By:

Dahl, Nathan A.;
Liu, Arthur K.;
Foreman, Nicholas K.;
Widener, Melissa;
Fenton, Laura Z.;
Macy, Margaret E.

Publication type:

Article

Pseudoprogression successfully treated with bevacizumab in a child with spinal pilocytic astrocytoma.

Published in:

2018

By:

Miyata, Kenji;
Hori, Toshinori;
Shimomura, Yasuto;
Okumura, Akihisa;
Joko, Masahiro;
Takayasu, Masakazu

Publication type:

Case Study

Vascular stenosis in a child with visual pathway glioma treated with bevacizumab: a case report and review of literature.

Published in:

2018

By:

Pilotto, Chiara;
Beshlawi, Ismail;
Thomas, Adam;
Grundy, Richard G.

Publication type:

Case Study

Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1431, doi. 10.1007/s00280-011-1601-4

By:

Fogelman, David;
Jafari, Mehrdad;
Varadhachary, Gauri;
Xiong, Henry;
Bullock, Susie;
Ozer, Harold;
Lin, E.;
Morris, Jeffrey;
Cunningham, Patti;
Bennett, Bronwyn;
Abbruzzese, James;
Wolff, Robert

Publication type:

Article

A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1199, doi. 10.1007/s00280-011-1606-z

By:

Zhi, Jianguo;
Chen, Eric;
Major, Pierre;
Burns, Ivon;
Robinson, Bridget;
McKendrick, Joe;
Rittweger, Karen;
Abt, Markus;
Goldstein, David

Publication type:

Article

Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1207, doi. 10.1007/s00280-011-1604-1

By:

De Stefano, Alfonso;
Carlomagno, Chiara;
Pepe, Stefano;
Bianco, Roberto;
De Placido, Sabino

Publication type:

Article

Evaluation of combined bevacizumab and intraperitoneal carboplatin or paclitaxel therapy in a mouse model of ovarian cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 951, doi. 10.1007/s00280-011-1566-3

By:

Shah, Dhaval;
Veith, Jean;
Bernacki, Ralph;
Balthasar, Joseph

Publication type:

Article

Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 3, p. 763, doi. 10.1007/s00280-010-1543-2

By:

Matsusaka, Satoshi;
Suenaga, Mitsukuni;
Mishima, Yuji;
Takagi, Koichi;
Terui, Yasuhito;
Mizunuma, Nobuyuki;
Hatake, Kiyohiko

Publication type:

Article

A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 293, doi. 10.1007/s00280-010-1478-7

By:

Kulke, Matthew;
Chan, Jennifer;
Meyerhardt, Jeffrey;
Zhu, Andrew;
Abrams, Thomas;
Blaszkowsky, Lawrence;
Regan, Eileen;
Sidor, Carolyn;
Fuchs, Charles

Publication type:

Article

Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 1, p. 217, doi. 10.1007/s00280-010-1475-x

By:

Polyzos, Aris;
Kalbakis, Kostas;
Kentepozidis, Nikolaos;
Giassas, Stylianos;
Kalykaki, Antonia;
Vardakis, Nikolaos;
Bozionelou, Vasiliki;
Saloustros, Emmanouel;
Kontopodis, Emmanouel;
Georgoulias, Vassilis;
Mavroudis, Dimitris

Publication type:

Article

Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 1, p. 263, doi. 10.1007/s00280-011-1633-9

By:

Horimatsu, Takahiro;
Miyamoto, Shin'ichi;
Morita, Shuko;
Mashimo, Yoko;
Ezoe, Yasumasa;
Muto, Manabu;
Chiba, Tsutomu

Publication type:

Article

Review on clinical trials of targeted treatments in malignant mesothelioma.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 1, p. 1, doi. 10.1007/s00280-011-1655-3

By:

Jakobsen, Jan;
Sørensen, Jens

Publication type:

Article

Corticorelin acetate, a synthetic corticotropin-releasing factor with preclinical antitumor activity, alone and with bevacizumab, against human solid tumor models.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1415, doi. 10.1007/s00280-010-1437-3

By:

Gamez, Idoia;
Ryan, Robert;
Reid, Lakesha;
Routt, Sheri;
Hollister, Beth

Publication type:

Article

Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 3, p. 723, doi. 10.1007/s00280-010-1457-z

By:

Lopez, Emiliano;
Rizzo, Manglio;
Croxatto, J.;
Mazzolini, Guillermo;
Gallo, Juan

Publication type:

Article

A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE).

Published in:

2011

By:

Bullock, Karen;
Petros, William;
Younis, Islam;
Uronis, Hope;
Morse, Michael;
Blobe, Gerard;
Yousuf Zafar, S.;
Gockerman, Jon;
Lager, Joanne;
Truax, Roxanne;
Meadows, Kellen;
Howard, Leigh;
O'Neill, Margot;
Broadwater, Gloria;
Hurwitz, Herbert;
Bendell, Johanna

Publication type:

Report

A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1051, doi. 10.1007/s00280-010-1257-5

By:

Ko, Andrew H.;
Venook, Alan P.;
Bergsland, Emily K.;
Kelley, R. Kate;
Korn, W. Michael;
Dito, Elizabeth;
Schillinger, Brian;
Scott, Janet;
Hwang, Jimmy;
Tempero, Margaret A.

Publication type:

Article

Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 4, p. 745, doi. 10.1007/s00280-009-1219-y

By:

Yagi, Yasumichi;
Fushida, Sachio;
Harada, Shinichi;
Tsukada, Tomoya;
Kinoshita, Jun;
Oyama, Katsunobu;
Fujita, Hideto;
Ninomiya, Itasu;
Fujimura, Takashi;
Kayahara, Masato;
Kinuya, Seigo;
Yashiro, Masakazu;
Hirakawa, Kousei;
Ohta, Tetsuo

Publication type:

Article

Effects of bevacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 3, p. 467, doi. 10.1007/s00280-009-1051-4

By:

Horita, Yosuke;
Yamada, Y.;
Hirashima, Y.;
Kato, K.;
Nakajima, T.;
Hamaguchi, T.;
Shimada, Y.

Publication type:

Article

Bevacizumab induced reversible thrombocytopenia in a patient with recurrent high-grade glioma: a case report.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 399, doi. 10.1007/s00280-009-1118-2

By:

Leal, Ticiana;
Robins, H. Ian

Publication type:

Article

Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 97, doi. 10.1007/s00280-009-1008-7

By:

Denlinger, Crystal S.;
Blanchard, Rebecca;
Lu Xu;
Bernaards, Coen;
Litwin, Samuel;
Spittle, Cynthia;
Berg, Daniel J.;
McLaughlin, Susan;
Redlinger, Maryann;
Dorr, Andrew;
Hambleton, Julie;
Holden, Scott;
Kearns, Anne;
Kenkare-Mitra, Sara;
Lum, Bert;
Meropol, Neal J.;
O'Dwyer, Peter J.

Publication type:

Article

The polyamine analog PG11047 potentiates the antitumor activity of cisplatin and bevacizumab in preclinical models of lung and prostate cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 191, doi. 10.1007/s00280-009-1105-7

By:

Dredge, K.;
Kink, J. A.;
Johnson, R. M.;
Bytheway, I.;
Marton, L. J.

Publication type:

Article

Hepatic portal venous gas in a patient with metastatic non-small cell lung cancer on bevacizumab therapy: a case report and review of the literature.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 187, doi. 10.1007/s00280-009-1104-8

By:

Ortega, Jose;
Hayes, J. Michael;
Antonia, Scott

Publication type:

Article

Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1065, doi. 10.1007/s00280-008-0811-x

By:

Chia-Chi Lin;
Calvo, Emiliano;
Papadopoulos, Kyriakos P.;
Patnaik, Amita;
Sarantopoulos, John;
Mita, Alain C.;
Preston, Glenn G.;
Mita, Monica M.;
Rodon, Jordi;
Mays, Theresa;
I.-Tien Yeh;
O'Rourke, Pat;
Takimoto, Chris H.;
Dancey, Janet E.;
Chen, Helen;
Tolcher, Anthony W.

Publication type:

Article

Pharmacokinetics and safety of bevacizumab administered in combination with cisplatin and paclitaxel in cynomolgus monkeys.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 4, p. 607, doi. 10.1007/s00280-007-0513-9

By:

Xu, Lu;
Zuch, Christina;
Lin, Yvonne;
Modi, Nishit;
Lum, Bert

Publication type:

Article

Impact of intravitreal anti-VEGF therapy on intraretinal microvascular abnormalities in proliferative diabetic retinopathy.

Published in:

Acta Diabetologica, 2024, v. 61, n. 4, p. 525, doi. 10.1007/s00592-023-02227-4

By:

De Geronimo, Daniele;
Parravano, Mariacristina;
Sacconi, Riccardo;
Fragiotta, Serena;
Giannini, Daniela;
Costanzo, Eliana;
Varano, Monica;
Querques, Giuseppe

Publication type:

Article

Evaluation of the efficacy of anti-vascular endothelial growth factors in diabetic macular edema with retinal inner and outer layers disorganization.

Published in:

Acta Diabetologica, 2023, v. 60, n. 10, p. 1391, doi. 10.1007/s00592-023-02121-z

By:

Kocapınar, Yıldırım;
Kaplan, Fatih Bilgehan;
Demirciler Sönmez, Ayşe;
Açıkalın, Banu

Publication type:

Article

Diabetic retinopathy, diabetic macular edema, and cardiovascular risk: the importance of a long-term perspective and a multidisciplinary approach to optimal intravitreal therapy.

Published in:

Acta Diabetologica, 2020, v. 57, n. 5, p. 513, doi. 10.1007/s00592-019-01453-z

By:

Bandello, Francesco;
Toni, Danilo;
Porta, Massimo;
Varano, Monica

Publication type:

Article

Phage display peptide probes for imaging early response to bevacizumab treatment.

Published in:

Amino Acids, 2011, v. 41, n. 5, p. 1103, doi. 10.1007/s00726-010-0548-9

By:

Cao, Qizhen;
Liu, Shuanglong;
Niu, Gang;
Chen, Kai;
Yan, Yongjun;
Liu, Zhaofei;
Chen, Xiaoyuan

Publication type:

Article

Efficacy of Bevacizumab plus Erlotinib for Advanced Hepatocellular Carcinoma and Predictors of Outcome: Final Results of a Phase II Trial.

Published in:

Oncology, 2012, v. 82, n. 2, p. 67, doi. 10.1159/000335963

By:

Kaseb, A.O.;
Garrett-Mayer, E.;
Morris, J.S.;
Xiao, L.;
Lin, E.;
Onicescu, G.;
Hassan, M.M.;
Hassabo, H.M.;
Iwasaki, M.;
Deaton, F.L.;
Abbruzzese, J.L.;
Thomas, M.B.

Publication type:

Article

Prolonged Survival of Patients with Metastatic Colorectal Cancer following First-Line Oxaliplatin-Based Chemotherapy with Molecular Targeting Agents and Curative Surgery.

Published in:

Oncology, 2011, v. 81, n. 3/4, p. 167, doi. 10.1159/000333404

By:

Shitara, Kohei;
Matsuo, Keitaro;
Kondo, Chihiro;
Takahari, Daisuke;
Ura, Takashi;
Inaba, Yoshitaka;
Yamaura, Hidekazu;
Sato, Yozo;
Kato, Mina;
Kanemitsu, Yukihide;
Komori, Koji;
Ishiguro, Seiji;
Sano, Tsuyoshi;
Shimizu, Yasuhiro;
Muro, Kei

Publication type:

Article

Combination Therapy for Renal Cell Cancer: What Are Possible Options?

Published in:

Oncology, 2011, v. 81, n. 3/4, p. 220, doi. 10.1159/000333470

By:

Santos, Napoleon;
Wenger, Justin B.;
Havre, Pamela;
Liu, Yanxia;
Dagan, Roi;
Imanirad, Iman;
Ivey, Alison M.;
Zlotecki, Robert A.;
Algood, Chester B.;
Gilbert, Scott M.;
Allegra, Carmen J.;
Okunieff, Paul;
Vieweg, Johannes;
Dang, Nam H.;
Luesch, Hendrik;
Dang, Long H.

Publication type:

Article

Phase I Study of Two Schedules of Oral S-1 in Combination with Fixed Doses of Oxaliplatin and Bevacizumab in Patients with Advanced Solid Tumors.

Published in:

Oncology, 2011, v. 81, n. 2, p. 65, doi. 10.1159/000331010

By:

Chung, Ki Y.;
Saito, Kaku;
Zergebel, Christopher;
Hollywood, Ellen;
Segal, Michal;
Saltz, Leonard B.

Publication type:

Article

VEGFR2 Expression and TGF-β Signaling in Initial and Recurrent High-Grade Human Glioma.

Published in:

Oncology, 2011, v. 81, n. 2, p. 126, doi. 10.1159/000332849

By:

Kuczynski, Elizabeth A.;
Patten, Steven G.;
Coomber, Brenda L.

Publication type:

Article

Safety of Bevacizumab in Patients with Metastatic Breast Cancer.

Published in:

Oncology, 2011, v. 80, n. 5/6, p. 314, doi. 10.1159/000328757

By:

Hamilton, Erika P.;
Blackwell, Kimberly L.

Publication type:

Article

Bevacizumab in the Treatment of Advanced, Non-Squamous Non-Small Cell Lung Cancer: An Evidence-Based Approach.

Published in:

Oncology, 2011, v. 80, n. 5/6, p. 350, doi. 10.1159/000328781

By:

Tassinari, Davide;
Sartori, Sergio;
Papi, Maximilian;
Drudi, Fabrizio;
Castellani, Cinzia;
Carloni, Federica;
Tombesi, Paola;
Lazzari-Agli, Luigi

Publication type:

Article

Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results?

Published in:

Oncology, 2011, v. 80, n. 3/4, p. 153, doi. 10.1159/000324704

By:

Kemeny, Nancy E.;
Schwartz, Lawrence;
Gönen, Mithat;
Yopp, Adam;
Gultekin, David;
D'Angelica, Michael I.;
Fong, Yuman;
Haviland, Dana;
Gewirtz, Alexandra N.;
Allen, Peter;
Jarnagin, William R.

Publication type:

Article

Reply to Dr. Kabbinavar and Dr. Kozloff.

Published in:

Oncology, 2011, v. 80, n. 1/2, p. 140, doi. 10.1159/000327226

By:

Stathopoulos, G.P.

Publication type:

Article

Immunological Effects of Bevacizumab-Based Treatment in Metastatic Colorectal Cancer.

Published in:

Oncology, 2011, v. 79, n. 3/4, p. 187, doi. 10.1159/000320609

By:

Manzoni, M.;
Rovati, B.;
Ronzoni, M.;
Loupakis, F.;
Mariucci, S.;
Ricci, V.;
Gattoni, E.;
Salvatore, L.;
Tinelli, C.;
Villa, E.;
Danova, M.

Publication type:

Article

Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis.

Published in:

Oncology, 2010, v. 79, n. 1/2, p. 27, doi. 10.1159/000314980

By:

Hapani, Sanjaykumar;
Sher, Amna;
Chu, David;
Shenhong Wu

Publication type:

Article